July 15 2013 – Compugen Announces US Patent Allowance for Drug Candidate Recently Presented at 2013 American Thoracic Society Meeting

Compugen Ltd. (NASDAQ: CGEN [FREE Stock Trend Analysis]) announced today that the  company has received an Issue Notification from the U.S. Patent and Trademark  Office for a patent application covering the company’s drug candidate  CGEN-25009. CGEN-25009 is intended for the treatment of idiopathic pulmonary  fibrosis, a devastating disease with no current effective treatment. This novel  peptide agonist of the relaxin receptor was the subject of a recent presentation  by Dr. Daniel Kass, from the University of Pittsburgh (“Pitt”), at the 2013  American Thoracic Society Conference.

In his presentation, Dr. Kass, Assistant Professor of Medicine at Pitt and  Assistant Director for Novel Therapeutics and Translational Research at The  Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease at the  University of Pittsburgh Medical Center, presented experimental data  demonstrating that CGEN-25009 protects mice from bleomycin-induced pulmonary  fibrosis. In this model, CGEN-25009 treatment reduced lung fibrosis as  determined by collagen deposition in both preventive and therapeutic  administration regimens.

Read more: http://www.benzinga.com/news/13/07/3751856/compugen-announces-us-patent-allowance-for-drug-candidate-recently-presented-at-2#ixzz2gCuFeKai

Read the entire article at:

http://www.benzinga.com/news/13/07/3751856/compugen-announces-us-patent-allowance-for-drug-candidate-recently-presented-at-2#ixzz2dlvECyB8

For more information about Idiopathic Pulmonary Fibrosis please visit our website www.ipftoday.com and don’t forget to like us on www.facebook.com/IPFToday

This entry was posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Medical, Pulmonary Fibrosis, Uncategorized and tagged , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>